Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

A novel magnetic approach to enhance the efficacy of cell-based gene therapies

Abstract

Attempts have been made to use various forms of cellular vectors to deliver therapeutic genes to diseased tissues like malignant tumours. However, this approach has proved problematic due to the poor uptake of these vectors by the target tissue. We have devised a novel way of using magnetic nanoparticles (MNPs) to enhance the uptake of such ‘therapeutically armed’ cells by tumours. Monocytes naturally migrate from the bloodstream into tumours, so attempts have been made to use them to deliver therapeutic genes to these sites. However, transfected monocytes injected systemically fail to infiltrate tumours in large numbers. Using a new in vitro assay for assessing monocyte extravasation, we show that the ability of transfected human monocytes to migrate across a human endothelial cell layer into a 3D tumour spheroid is markedly increased when cells are pre-loaded with MNPs and a magnetic force is applied close to the spheroid. Furthermore, systemic administration of such ‘magnetic’ monocytes to mice bearing solid tumours led to a marked increase in their extravasation into the tumour in the presence of an external magnet. This new magnetic targeting approach could be used to increase the targeting, and thus the efficacy, of many cell-based gene therapies in vivo.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Luo D, Saltzman WM . Enhancement of transfection by physical concentration of DNA at the cell surface. Nat Biotechnol 2000; 18: 893–895.

    Article  CAS  PubMed  Google Scholar 

  2. Emens LA, Jaffee EM . Cancer vaccines: an old idea comes of age. Cancer Biol Ther 2003; 2: S161–S168.

    Article  PubMed  Google Scholar 

  3. Leek RD, Landers RJ, Harris AL, Lewis CE . Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer 1999; 79: 991–995.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Burke B, Giannoudis A, Corke KP, Gill D, Wells M, Ziegler-Heitbrock L et al. Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy. Am J Pathol 2003; 163: 1233–1243.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Griffiths L, Binley K, Iqball S, Kan O, Maxwell P, Ratcliffe P et al. The macrophage—a novel system to deliver gene therapy to pathological hypoxia. Gene Therapy 2000; 7: 255–262.

    Article  CAS  PubMed  Google Scholar 

  6. Bartoleyns J, Romet-Lemonne JL, Chokri M, Lopez M . Immune therapy with macrophages: present status and critical requirements for implementation. Immunobiology 1996; 195: 550–562.

    Article  CAS  PubMed  Google Scholar 

  7. Andreesen R, Hennemann B, Krause SW . Adoptive immunotherapy of cancer using monocyte-derived macrophages: rationale, current status, and perspectives. J Leukoc Biol 1998; 64: 419–426.

    Article  CAS  PubMed  Google Scholar 

  8. Bartholeyns J, Lopez M, Andreesen R . Adoptive immunotherapy of solid tumors with activated macrophages: experimental and clinical results. Anticancer Res 1991; 11: 1201–1204.

    CAS  PubMed  Google Scholar 

  9. Burke B, Tang N, Corke KP, Tazzyman D, Ameri K, Wells M et al. Expression of HIF-1alpha by human macrophages: implications for the use of macrophages in hypoxia-regulated cancer gene therapy. J Pathol 2002; 196: 204–212.

    Article  CAS  PubMed  Google Scholar 

  10. Freeman AAaM . Magnetism in medicine. J Appl Phys 1960; 51: S404–S405.

    Article  Google Scholar 

  11. Lubbe AS, Bergemann C, Riess H, Schriever F, Reichardt P, Possinger K et al. Clinical experiences with magnetic drug targeting: a phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res 1996; 56: 4686–4693.

    CAS  PubMed  Google Scholar 

  12. Goodwin SC, Bittner CA, Peterson CL, Wong G . Single-dose toxicity study of hepatic intra-arterial infusion of doxorubicin coupled to a novel magnetically targeted drug carrier. Toxicol Sci 2001; 60: 177–183.

    Article  CAS  PubMed  Google Scholar 

  13. Arruebo MF-PR, Ibarra R, Santamaría J . Magnetic nanoparticles for drug delivery. Nanotoday 2007; 2: 22–32.

    Article  Google Scholar 

  14. Wang MD, Shin DM, Simons JW, Nie S . Nanotechnology for targeted cancer therapy. Expert Rev Anticancer Ther 2007; 7: 833–837.

    Article  CAS  PubMed  Google Scholar 

  15. Kooi ME, Cappendijk VC, Cleutjens KB, Kessels AG, Kitslaar PJ, Borgers M et al. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 2003; 107: 2453–2458.

    Article  CAS  PubMed  Google Scholar 

  16. von Zur Muhlen C, von Elverfeldt D, Bassler N, Neudorfer I, Steitz B, Petri-Fink A et al. Superparamagnetic iron oxide binding and uptake as imaged by magnetic resonance is mediated by the integrin receptor Mac-1 (CD11b/CD18): implications on imaging of atherosclerotic plaques. Atherosclerosis 2007; 193: 102–111.

    Article  CAS  PubMed  Google Scholar 

  17. Metz S, Bonaterra G, Rudelius M, Settles M, Rummeny EJ, Daldrup-Link HE . Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur Radiol 2004; 14: 1851–1858.

    Article  PubMed  Google Scholar 

  18. Robinson DM, Keating GM . Albumin-bound Paclitaxel: in metastatic breast cancer. Drugs 2006; 66: 941–948.

    Article  CAS  PubMed  Google Scholar 

  19. Yellen BB, Hovorka O, Friedman G . Arranging matter by magnetic nanoparticle assemblers. Proc Natl Acad Sci USA 2005; 102: 8860–8864.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Mayrovitz HN, Tuma RF, Wiedeman MP . Relationship between microvascular blood velocity and pressure distribution. Am J Physiol 1977; 232: H400–H405.

    CAS  PubMed  Google Scholar 

  21. Schenkel AR, Mamdouh Z, Muller WA . Locomotion of monocytes on endothelium is a critical step during extravasation. Nat Immunol 2004; 5: 393–400.

    Article  CAS  PubMed  Google Scholar 

  22. Jin H, Su J, Garmy-Susini B, Kleeman J, Varner J . Integrin alpha4beta1 promotes monocyte trafficking and angiogenesis in tumors. Cancer Res 2006; 66: 2146–2152.

    Article  CAS  PubMed  Google Scholar 

  23. Ross JA . The Biology of the Macrophage. Oxford: Oxford University Press, 2002.

    Google Scholar 

  24. Daldrup-Link HE, Rudelius M, Oostendorp RA, Settles M, Piontek G, Metz S et al. Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology 2003; 228: 760–767.

    Article  PubMed  Google Scholar 

  25. Verdijk P, Scheenen TW, Lesterhuis WJ, Gambarota G, Veltien AA, Walczak P et al. Sensitivity of magnetic resonance imaging of dendritic cells for in vivo tracking of cellular cancer vaccines. Int J Cancer 2007; 120: 978–984.

    Article  CAS  PubMed  Google Scholar 

  26. Strom VHK, Gruttner C, Teller J . A novel and rapid method for quantification of magnetic nanoparticle–cell interactions using a desktop susceptometer. Nanotechnology 2004; 15: 457–466.

    Article  Google Scholar 

  27. Anderson SA, Shukaliak-Quandt J, Jordan EK, Arbab AS, Martin R, McFarland H et al. Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis. Ann Neurol 2004; 55: 654–659.

    Article  PubMed  Google Scholar 

  28. Murdoch C, Tazzyman S, Webster S, Lewis CE . Expression of Tie-2 by human monocytes and their responses to angiopoietin-2. J Immunol 2007; 178: 7405–7411.

    Article  CAS  PubMed  Google Scholar 

  29. Lim YC, Snapp K, Kansas GS, Camphausen R, Ding H, Luscinskas FW . Important contributions of P-selectin glycoprotein ligand-1-mediated secondary capture to human monocyte adhesion to P-selectin, E-selectin, and TNF-alpha-activated endothelium under flow in vitro. J Immunol 1998; 161: 2501–2508.

    CAS  PubMed  Google Scholar 

  30. Lawrence MB, Springer TA . Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell 1991; 65: 859–873.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC), UK. JD acknowledges the support of a Royal Society Wolfson Research Merit Award.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C E Lewis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Muthana, M., Scott, S., Farrow, N. et al. A novel magnetic approach to enhance the efficacy of cell-based gene therapies. Gene Ther 15, 902–910 (2008). https://doi.org/10.1038/gt.2008.57

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gt.2008.57

Keywords

This article is cited by

Search

Quick links